Contributor Page
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 4084000
Fax: +1 202 4084400
901 New York Avenue, NW
Washington, DC
20001-4413
United States
By Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
DOCX is part of the USPTO's eMod efforts to expand the filing formats used for filing patent applications.
By J. Michael Jakes
Welcome to the Last Month at the Federal Circuit, a look at recent Federal Circuit decisions impacting the intellectual property community.
By J. Michael Jakes
Welcome to the Last Month at the Federal Circuit, a look at recent Federal Circuit decisions impacting the intellectual property community.
By Megan L. Meyers, Samhitha Muralidhar Medatia
In BioDelivery Sciences International, Inc. v. Aquestive Therapeutics, Inc., Nos. 19-1643, 19-1644, 19-1645 (Fed. Cir. Aug. 29, 2019), the Federal Circuit granted Aquestive
By Victor Feng, Samhitha Muralidhar
In Guangdong Alison Hi-Tech Co. v. International Trade Commission, No. 2018-2042 (Fed. Cir. Aug. 27, 2019), the Federal Circuit affirmed the ITC's findings that the claims of U.S.
By Yieyie Yang, Samhitha Muralidhar Medatia
In Allergan Sales, LLC v. Sandoz, Inc., No. 2018-2207 (Fed. Cir. Aug. 29, 2019), the Federal Circuit held that the "wherein" clauses in Allergan's method-of-treatment claims are limiting.
By Michelle (Yongyuan) Rice, Aaron Capron
In Polaris Indus., Inc. v. Arctic Cat Inc., the court (District of Minnesota) held that defendant was not estopped under § 315(e)(2) from asserting three invalidity combinations involving physical
By Thomas Irving, Stacy Lewis
This practice note teaches patent prosecutors how to overcome a patent examiner's obviousness rejection by attacking the examiner's prima facie case.
By Fionnuala Richardson, Margaret Esquenet
By way of background, in 2014 Shoe Branding Europe filed an invalidation action against adidas AG's EU Registration No. 12442166
By Jonathan Uffelman, Margaret Esquenet
Brand owners seeking to acquire a cybersquatting domain name may file either a lawsuit under the Anti-cybersquatting Consumer Protection Act ("ACPA") or an arbitration complaint under the
By Gerson Panitch
In the late 1990's, Stephen Dickerson, then a Professor at Georgia Tech, developed what he claims is the basis for all ridesharing technology
By Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The expanded Collaborative Search Pilot (CSP), running from November 1, 2017 through October 31, 2020,
By Fionnuala Richardson, Clare Cornell
Instagram is swiftly becoming the world's number one hot spot for advertisement.
By Nicholas Doyle, Sydney Kestle
In Nalpropion Pharmaceuticals v. Actavis Laboratories FL, Inc., No. 2018-1221, the Court addressed whether a particular claimed dissolution profile had the requisite written description support.
By Andrew Renison, Matthew J. Hlinka, Justin J. Hasford
The development of pharmaceutical products is often expensive and unpredictable. Researchers investing the time and resources to develop a novel and non-obvious advancement over the art are rewarded with patent protection
Contributor's Topics
More...